Cancer mortality in Down syndrome in California

International Journal on Disability and Human Development

Volumn 7, Issue 4, 2008, Pages 413-424

  Sasco, Annie J ^a   Day, Steven M ^b   Strauss, David J ^b   Shavelle, Robert M ^b   Voirin, Nicolas ^c   Satgé, Daniel ^d  

^a INSERM   (France)

^b Life Expectancy Proj San Francisco   (United States)

^c UNIVERSITÉ DE LYON   (France)

^d CENTRE HOSPITALIER   (France)

Author keywords

cancer; Down syndrome; leukemia; liver cancer; lymphoma; mortality; testicular cancer

Indexed keywords

ARTICLE; BLADDER CANCER; BONE CANCER; BREAST CANCER; CANCER MORTALITY; COLON CANCER; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; LEUKEMIA; LIP CANCER; LIVER CANCER; LYMPHATIC LEUKEMIA; LYMPHOMA; MOUTH CANCER; MYELOID LEUKEMIA; PHARYNX CANCER; SKIN CANCER; STANDARDIZED MORTALITY RATIO; TESTIS CANCER; UNITED STATES;

EID: 59049093157     PISSN: 21911231     EISSN: 21910367     Source Type: Journal    
DOI: 10.1515/IJDHD.2008.7.4.413     Document Type: Article

References (38)

1. Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami HO, et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 2003;163(6):705-11.
2. Boker LK, Blumstein T, Sadetzki S, Luxenburg O, Litvak I, Akstein E, et al. Incidence of leukemia and other cancers in Down syndrome subjects in Israel. Int J Cancer 2001;93(5):741-4.
3. Boker LK, Merrick J. Cancer. incidence in persons with Down syndrome in Israel. Downs Syndr Res Pract 2002;8(1 ):31-6.
4. Hermon C, Alberman E, Beral V, Swerdlow AJ. Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings. Ann Hum Genet 2001;65(Pt 2): 167-76.
5. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 2004;89(11): 1014-7.
6. Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M. Cancer incidence of persons with Down syndrome in Finland: a population-based study. Int J Cancer 2006; 118(7): 1769-72.
7. Sullivan SG, Hussain R, Glasson EJ, Bittles AH. The profile and incidence of cancer in Down syndrome. J Intellect Disabil Res 2007;51(Pt 3): 228-31.
8. Satg6 D, Sasco AJ, Lacour B. Are solid tumours different in children with Down's syndrome? Int J Cancer 2003;106(2):297-8.
9. Satgé D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M. A tumour profile in Down syndrome. Am J Med Genet 1998;78(3):207-16.
10. Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2001;2(7):429-36.
11. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000;355(9199): 165-9.
12. Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol 2005;47(3):171-6.
13. Leonard S, Bower C, Petterson B, Leonard H. Survival of infants born with Down's syndrome: 1980-96. Paediatr Perinat Epidemiol 2000; 14(2): 163-71.
14. Practice Management Information Corporation., United States. Health Care Financing Administration. ICD-9-CM: international classification of diseases, 9th revision, clinical modification, fifth edition, color coded, volumes 1 and 2. Hospital ed. Los Angeles, CA: PMIC (Practice Management Information Corp.), 2000.
15. California Department of Developmental Services. Client Development Evaluation Report (CDER). Sacramento, CA: Calif Dept Devi Serv, 1986.
16. Citygate Associates. Independent evaluation of the Department of Developmental Services community placement practices: final technical report. Sacramento, CA: Citygate Associates, 1998.
17. Eyman RK, Call TL. Life expectancy of persons with Down syndrome. Am J Ment Retard 1991;95(6):603-12.
18. State of California, Department of Health Services, Center for Health Statistics, Office of Health Information and Research. Annual electronic death records, 1988-2002.
19. State of California, Department of Finance. Race/ Ethnic Population with Age and Sex Detail, 19702040. Sacramento, CA: Dept Finance, 1988.
20. Kahn HA, Sempos CT, Kahn HA. Statistical methods in epidemiology. New York: Oxford Univ Press, 1989.
21. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002;359(9311): 1019-25.
22. Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down's syndrome. Acta Paediatr Scand 1975;64(2):322-6.
23. Holland WW, Doll R, Carter CO. The mortality from leukaemia and other cancers among patients with Down's syndrome (mongols) and among their parents. Br J Cancer 1962;16:177-86.
24. Scholl T, Stein Z, Hansen H. Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev Med Child Neurol 1982;24 (6): 817-29.
25. Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, et al. The DNA sequence of human chromosome 21. Nature 2000;405(6784): 311-9.
26. Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 2004; 103(2):399-406.
27. Barber R, Spiers P. Oxford Survey Of Childhood Cancers; Progress Report II. Mon Bull Minist Health Public Health Lab Serv 1964;23:46-52.
28. Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunological features of Down's syndrome: a review. J Intellect Disabil Res 1993;37 (Pt 6):543-51.
29. Vellinga A, Van Damme P, Meheus A. Hepatitis B and C in institutions for individuals with intellectual disability. J Intellect Disabil Res 1999;43 (Pt 6):445-53.
30. International Agency for Research on Cancer. IARC Monogr Eval Carcinog Risks Hum Volume 59: Hepatitis viruses. Geneva: WHO, 1994; 1-286.
31. Satgé D, Sasco AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ. An excess of testicular germcell tumours in Down's syndrome: three case reports and a review of the literature. Cancer 1997;80(5):929-35.
32. Smucker JD, Roth LM, Sutton GP, Hurteau JA. Trisomy 21 associated with ovarian dysgermi-noma. Gynecol Oncol 1999;74(3):512-4.
33. Satge D, Sasco AJ, Pujol H, Rethore MO. (Breast cancer in women with trisomy 21). Bull Acad Natl Med 2001; 185(7): 1239-52; discussion 1252-4.
34. Cento RM, Ragusa L, Proto C, Alberti A, Romano C, Boemi G, et al. Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. Gynecol Endocrinol 1996; 10(2): 133-7.
35. Satgé D, Sasco AJ, Vekemans MJ, Portal ML, Flejou JF. Aspects of digestive tract tumours inDown syndrome: a literature review. Dig Dis Sci 2006;51(11 ):2053-61.
36. Lee EB, Park TI, Park SH, Park JY. Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer. Ann Thorac Surg 2003;75(5): 1597-600.
37. Yamamoto N, Uzawa K, Miya T, Watanabe T, Yokoe H, Shibahara T, et al. Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: evidence for three discrete tumour suppressor gene loci. Oncol Rep 1999;6(6): 1223-7.
38. International Agency for Research on Cancer. IARC Monogr Eval Carcinog Risks Hum Volume 83. Tobacco smoke and involuntary smoking. Lyon: IARC Press 2004;83:1-1438.